Thermo Fisher Scientific and Genovis, a provider of enzyme products for biological drug development, announced a collaborative research project. The aim of the collaboration is to develop advanced end-to-end workflows for the preparation, characterization and monitoring of novel and complex biotherapeutics using liquid chromatography-mass spectrometry (LC-MS).
Thermo Fisher Scientific and Symphogen, a clinical-stage antibody oncology-focused company, have entered into a two-year collaborative partnership to deliver validated, platform workflows for simplified characterization and quality monitoring of complex therapeutic proteins.
The next generation of biofuels will need the next generation of laboratory technology—With ever tightening regulations and the need to gain access to analytical data anytime and anywhere, LIMS (Laboratory Information Management Systems) become a key driver of biofuels production. In fact, the quest for the alternative energy sources might well be decided in the lab.
Thermo Fisher subsidiary Doe & Ingalls grow: The company just celebrated the opening of its new 5,200 square meter chemical distribution facility. This new expansion project shall help to deliver supply chain assurance, regulatory compliance and operational efficiency for life science customers.
Für umgerechnet 1,58 Milliarden Euro will Thermo Fisher Scientific den Chromatographie-Spezialisten Dionex übernehmen. Der Aufsichtsrat von Dionex hat dieser Offerte am 13. Dezember bereits zugestimmt.